1,25-dihydroxyvitamin D3 potentiates the decreased response of lymphocytes from atopic subjects to agents that increase intracellular cyclic adenosine monophosphate
- 31 December 1990
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 86 (6) , 881-885
- https://doi.org/10.1016/s0091-6749(05)80150-2
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- The immunobiology ofvitamin D: William F.C. RigbyImmunology Today, 1988
- The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune responseImmunology Today, 1988
- 1,25-Dihydroxyvitamin D attenuates cAMP accumulation in cultured human lymphocytesMolecular and Cellular Endocrinology, 1987
- 1,25‐Dihydroxyvitamin D3 enhances prostaglandin E2 production by monocytesFEBS Letters, 1986
- Impaired lymphocyte cyclic adenosine mono-phosphate responses in atopic eczemaBritish Journal of Dermatology, 1983
- Elevated leukocyte cyclic AMP—phosphodiesterase in atopic disease: a possible mechanism for cyclic AMP—agonist hyporesponsivenessJournal of Allergy and Clinical Immunology, 1982
- Abnormal Histamine-Induced Suppressor-Cell Function in Atopic SubjectsNew England Journal of Medicine, 1982
- Heterologous desensitization of leukocytes: a possible mechanism of beta adrenergic blockade in atopic dermatitisJournal of Allergy and Clinical Immunology, 1981
- Histamine suppression of human lymphocyte responses to mitogensCellular Immunology, 1978
- The beta adrenergic theory of the atopic abnormality in bronchial asthmaJournal of Allergy, 1968